Lung Cancer Newswire

Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

​Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from …

AI may boost early detection of TB, lung cancer in India: experts at NAPCON 2026

Jaipur: Artificial intelligence could be a game-changer in India's fight against tuberculosis (TB) and lung cancer by helping doctors identify suspicious abnormalities early, prioritise high-risk patients and accelerate further investigations. Experts …

Tennessee Oncology Researchers Help Lead Global Trial of Next-Generation Lung Cancer Therapy

Research Conducted at Tennessee Oncology's Greco-Hainsworth Centers for Research Contributes to Study Showing Longer Overall Survival with Next-Generation KRAS G12C Therapy NASHVILLE, Tenn., Oct. 25, 2026 /PRNewswire/ -- Researchers at …

Bristol Myers and BioNTech report early lung-cancer trial results

Bristol Myers Squibb and BioNTech reported early clinical results for their experimental cancer drug pumitamig on October 25, adding data to a partnership carrying billions of dollars in potential payments. The companies’ Phase 2 ROSETTA Lung-107 update …

TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death ...

WILMINGTON, Del.--(BUSINESS WIRE)--Oct 25, 2026-- Positive results from the SAFFRON Phase III trial showed TAGRISSO ® (osimertinib) plus savolitinib demonstrated a statistically significant and clinically meaningful improvement in both progression-free …

Pope's lung cancer is a reminder that nonsmokers can be at risk. What to know

SALT LAKE CITY — Pope Leo XIV's lung cancer diagnosis and surgery are good reminders that even those who never smoked can get lung cancer, too. On Oct. 16, Dr. John Stringham, a thoracic and oncology surgeon for Intermountain Health, briefed members of …

Roche says divarasib cut risk of death 44% in lung cancer trial

ZURICH, Oct 25 (Reuters) – Swiss drugmaker Roche said on Sunday its experimental lung cancer drug divarasib reduced the ​risk of death by 44% ‌compared with existing treatments in a phase III study. • Roche said patients with previously treated KRAS G12C- …

Genentech's Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS ...

Divarasib monotherapy demonstrated superior efficacy over first-generation KRAS G12C inhibitors, lowering the risk of disease progression or death by 42% and the overall risk of death by 44%, in the Phase III Krascendo 1 study At the time of primary …

Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS ...

SOUTH SAN FRANCISCO, Calif. — Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today pivotal results from the Phase III Krascendo 1 study, which demonstrated the superior efficacy of investigational divarasib, a next- …

AI can help doctors detect TB and lung cancer earlier: Dr Randeep Gule...

New Delhi, October 25 (IANS) Artificial intelligence (AI) could play a transformative role in India's fight against tuberculosis (TB) and lung cancer by supporting earlier detection, faster diagnosis and more efficient patient screening, experts said …

ESMO 2026: New Targeted Therapy Improved Survival for Patients with KRAS-Mutated Lung Cancer

Phase 3 trial finds that next-generation KRAS G12C inhibitor divarasib significantly reduced risk of cancer progressing and death  Patients receiving divarasib lived a median of approximately 18 months   Fewer severe treatment-related side effects were …

'Six years on, I'm still stable': Finally a shred of hope for deadly lung cancer patients as NHS drug gives precious ...

Doctors today hailed a major advance in the fight against lung cancer after a treatment already available on the NHS was shown to give patients precious extra months of life.  Advanced lung cancer is one of the most brutal forms of the disease - with just …

Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer

This article was published on October 24, 2026, at NEJM.org. Supported by Amgen and AstraZeneca. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank Ying Cheng, M.D. (Jilin Cancer Hospital, …

Amgen says 'breakthrough' drug improves lung cancer survival rate by 58 per cent

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. Join today Already a member? Log in Combining the Amgen drug Imdelltra with AstraZeneca’s immunotherapy Imfinzi reduces the risk of …

Acute Myeloid Leukemia Reported 32 Months After Icotinib Therapy for EGFR-Mutated Lung Cancer

Oncologists in Wuhan, China, have reported that a 75-year-old woman with EGFR-mutated lung adenocarcinoma developed acute myeloid leukemia roughly 32 months after starting icotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. The case, …

IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung ...

WILMINGTON, Del.--(BUSINESS WIRE)--Oct 24, 2026-- Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI ® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in the …

New lung cancer combo cuts risk of death by 58%

A new combination treatment for one of the most aggressive forms of lung cancer reduced the risk of death by 58% and extended patients' median survival by more than eight months, according to a major Phase 3 clinical trial published Saturday in the New …

‘Practice-changing’ new lung cancer immunotherapy improves survival

New Amgen drug combination shows survival gains in lung cancer trial

According to data from a study unveiled at a leading medical symposium on Saturday, Amgen’s Imdelltra used in combination with AstraZeneca’s immunotherapy Imfinzi decreased mortality risk by 58% compared to the Astra drug alone in patients with extensive- …

Health practices can now send eScripts directly from the patient record in Zanda

New integration lets authorised prescribers create, send and manage electronic prescriptions from Zanda, with patient details synced automatically. BALLARAT, VICTORIA, AUSTRALIA, October 26, 2026 /⁨EINPresswire.com⁩/ -- Zanda, the global …

Contact Lens Manufacturers: A Buyer's Guide to Vetting Top 10 Suppliers

BAIYIN, GANSU, CHINA, October 26, 2026 /⁨EINPresswire.com⁩/ -- Contact lens sourcing rarely fails on price. It fails on what a quotation does not show: whether the supplier owns the line, whether the certificate covers the product you are buying, …

Rx2BFIT Physician Shares Sleep and Recovery Guidance for End of Daylight Saving Time

With the November 1 time change, Dr. Bhavesh Patel, D.O., of Rx2BFIT in Artesia, CA explains how shorter days can affect sleep and recovery. ARTESIA, CA, UNITED STATES, October 26, 2026 /⁨EINPresswire.com⁩/ -- Daylight saving time ends Sunday, …

Hanwell Dental Centre Looks at What Families Should Consider When Choosing a Dentist

Comprehensive family dental care in Hanwell. Offering preventive dentistry, Invisalign, and dental implants tailored for all age groups. OLDHAM , ENGLAND , UNITED KINGDOM, October 26, 2026 /⁨EINPresswire.com⁩/ -- Finding a suitable dental practice …

The Sarcoma Oncology Center Announces Promising Clinical Data for DeltaRex-G Gene Therapy at ESMO 2026, Madrid, Spain

Data Update demonstrates significant clinical benefit and survival improvements in advanced, chemoresistant sarcomas, pancreas, breast and ovarian cancer LOS ANGELES, CA, UNITED STATES, October 26, 2026 /⁨EINPresswire.com⁩/ -- The Sarcoma Oncology …

Michigan School of Botanical Medicine: Clinical Herbalism Rooted in Community Care

In Dexter and Ypsilanti, Michigan, the school connects hands-on learning and clinical reasoning with a decade of community care. DEXTER, MI, UNITED STATES, October 26, 2026 /⁨EINPresswire.com⁩/ -- The Michigan School of Botanical Medicine, the …

ABIS Shares Vagus Nerve Stimulation Device Supplier Selection Guide

ABIS outlines certification checks, quality controls and OEM/ODM sourcing considerations for Vagus Nerve Stimulation Device SHENZHEN, GUANG-DONG, GHANA, October 25, 2026 /⁨EINPresswire.com⁩/ -- Sleep and wellness brands sourcing a Vagus Nerve …

Chenin Orthodontic Group Honored for 7,000 Treated Invisalign® Cases at 2026 Invisalign International Orthodontic Summit

A Milestone of Global Distinction: Chenin Orthodontic Group Among the World’s Most Experienced Invisalign Providers LAS VEGAS, NV, UNITED STATES, October 25, 2026 /⁨EINPresswire.com⁩/ -- Chenin Orthodontic Group is proud to announce that it was …

VandS Hair Clinic Highlights Hair Survival and Precision Design

VandS Hair Clinic highlights precision hairline design, hair survival, and personalized aftercare for natural-looking results. SEOUL, SOUTH KOREA, October 26, 2026 /⁨EINPresswire.com⁩/ -- As interest in hair loss treatment and aesthetic care …

From Animal Source to Full-Chain Controllability: Cloud-Clone Primary Cells for Customized Research Needs

In-house SPF animal facility enables traceable, tailor-made primary cell solutions for life-science and drug-discovery projects HUSTON, TX, UNITED STATES, October 26, 2026 /⁨EINPresswire.com⁩/ -- Primary cells serve as the gold-standard in-vitro …

ACS Nano Study Presents Multifunctional Nanotherapy Modulating the Joint-Brain Axis for Rheumatoid Arthritis

Cloud-Clone antibodies enable key target biomarker detection to validate dual peripheral-central therapeutic effects HUSTON, TX, UNITED STATES, October 26, 2026 /⁨EINPresswire.com⁩/ -- Rheumatoid arthritis (RA) is widely recognized as a chronic …

Nature Communications Study Reveals Angiotensin-II-Driven Mechanism for Exacerbated Intracerebral Hemorrhage

Cloud-Clone ELISA kits and monoclonal antibody deliver critical tools for unraveling receptor-independent coagulation dysregulation HUSTON, TX, UNITED STATES, October 26, 2026 /⁨EINPresswire.com⁩/ -- Hypertensive intracerebral hemorrhage (ICH) carries …

Study Uncovers Hypertension‑Osteoarthritis Link via AVP‑AVPR1A Axis

Cloud-Clone Copeptin ELISA kits deliver critical quantitative evidence supporting the landmark neuroendocrine crosstalk discovery HUSTON, TX, UNITED STATES, October 26, 2026 /⁨EINPresswire.com⁩/ -- Osteoarthritis (OA) ranks among the most …

The Vitamin Gummy Supplements Market for Children Is Projected to Grow Rapidly at a 9.8% CAGR Until 2030

The Business Research Company's The Vitamin Gummy Supplements Market for Children Is Projected to Grow Rapidly at a 9.8% CAGR Until 2030 LONDON, GREATER LONDON, UNITED KINGDOM, October 26, 2026 /⁨EINPresswire.com⁩/ -- "The market for vitamin …

Competitive Landscape of the Artificial Intelligence in Healthcare Market Examined Among Top Global Companies

The Business Research Company’s Competitive Landscape of the Artificial Intelligence in Healthcare Global Market Report 2026 – Market Size, Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, October 26, 2026 /⁨EINPresswire.com⁩/ -- The …

Vitamin Drop Market Expected to Reach $2.92 Billion by 2030 Driven by Robust Industry Expansion

The Business Research Company's Vitamin Drop Market Expected to Reach $2.92 Billion by 2030 Driven by Robust Industry Expansion LONDON, GREATER LONDON, UNITED KINGDOM, October 26, 2026 /⁨EINPresswire.com⁩/ -- "The vitamin drop market has …

Indiana Handicap Parking Placards: HandicapMD Explains Online Medical Certification and Eligibility

Indiana handicap placard guidance explains State Form 42070, medical certification, and government application steps. INDIANAPOLIS, IN, UNITED STATES, October 25, 2026 /⁨EINPresswire.com⁩/ -- HandicapMD is highlighting Indiana disability parking permit …

Mints and Mouthwash Mask the Problem: Langley’s 200 St Dentist on the Real Causes of Persistent Bad Breath

200th Street Langley Dentist explains why bad breath can return soon after brushing, the most common causes, and the daily habits that may help keep it away. LANGLEY, BRITISH COLUMBIA, CANADA, October 25, 2026 /⁨EINPresswire.com⁩/ -- Bad breath that …

Global fish oil supply under pressure as production heads towards decade low

Disruptions to Peru's anchovy season raise questions about omega-3 supply, highlighting the importance of diversification and responsible ocean management. MORNINGTON, AUSTRALIA, October 26, 2026 /⁨EINPresswire.com⁩/ -- The early closure of …

Miracle Surrogacy Welcomes More Than 30 Families to Private Consultations in Washington, D.C.

The October 23–25 meetings gave prospective parents an opportunity to discuss surrogacy in Mexico directly with the Miracle Surrogacy team. WASHINGTON, DC, UNITED STATES, October 25, 2026 /⁨EINPresswire.com⁩/ -- More than 30 families attended Miracle …